SCHEMBL6892381

SCHEMBL6892381

CCc1cccc(CNC(Cc2cc(F)cc(F)c2)[C@H](O)CNC(=O)c2ccc(O)c(C(=O)N3CCCCC3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.44
CTSD P07339 2/20 0.43
CTSB P07858 12/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3353523 0.88 BACE1 (0.57) BACE1CTSDCTSB
SCHEMBL3353519 0.88 BACE1 (0.57) BACE1CTSDCTSB
SCHEMBL3347592 0.87 BACE1 (0.57) BACE1CTSDCTSB
SCHEMBL3347586 0.87 BACE1 (0.57) BACE1CTSDCTSB
SCHEMBL6887164 0.83 BACE1 (0.47) BACE1CTSD
SCHEMBL3352932 0.81 BACE1 (0.62) BACE1CTSD
SCHEMBL3352925 0.81 BACE1 (0.62) BACE1CTSD
SCHEMBL3352718 0.81 BACE1 (0.55) BACE1CTSDCTSB
SCHEMBL3350619 0.81 BACE1 (0.55) BACE1CTSDCTSB
SCHEMBL3352733 0.81 BACE1 (0.55) BACE1CTSDCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed